Management Team
DR. CHRISTOPHER TING
GROUP MANAGING DIRECTOR & CEO
EXECUTIVE DIRECTOR, PAH (AUSTRALIA)
- Co-founder of Pathology Asia
- Co-founder of Biomark
- Former CEO of Innovative Diagnostics
- Founder of Quantum Diagnostics
- Former CEO of Quest Laboratories and Gribbles Pathology
- Former Assistant Head (Biomedical Sciences Group) at the Economic Development Board of Singapore
- Clinically trained
NABIL FAWZI
DEPUTY GROUP CEO
- Founding CFO of Pathology Asia
- Over 20 years of corporate experience, including 10 years of Corporate Finance and M&A
- Previously led EY Asia Pacific’s Healthcare Corporate Finance / M&A as Director of APAC Origination
- Former Director of Corporate Finance, PwC Singapore
- Started his career with UEM Group, a subsidiary of Khazanah Nasional Berhad
- Led and executed over USD10 billion worth of M&A and investment deals across Southeast Asia throughout his career
RAJKUMAR RENGARAJU
DEPUTY GROUP CEO & GROUP COO
- Founding Management Team Member of Pathology Asia
- More than 20 years of experience in the medical laboratory industry
- Spearheaded multiple quality initiatives including CAP and ISO 15189 accreditation; and Westgard Verification
- Led and managed multiple mergers and laboratory rollout’s
- Leads Pathology Asia’s drive to operational and reputaional excellence.
CHRIS SKENNERTON
Group CTO
- Joined Pathology Asia in early 2022
- Over 30 years in digital innovation and transformation, operations, software engineering and lab information systems
- Previously with 4Cyte Pathology, Healius, GE Healthcare and the Royal Australian Air Force